This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To evaluate the safety and tolerability of phenylbutyrate as compared to placebo for four weeks followed by open-label phenylbutyrate in individuals with HD; to examine the effects of phenylbutyrate on HD symptoms including movement, mood and mental functioning.
Showing the most recent 10 out of 1825 publications